EcoDrugPlus

Protein Kinase C Beta

Ensembl ID : ENSRFEG00010015032
Gene Symbol: PRKCB
1 Cross references
286 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSRFEG00010021234
Gene Symbol: PRKCD
1 Cross references
280 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSRFEG00010005919
Gene Symbol: PRKCE
1 Cross references
316 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSRFEG00010003473
Gene Symbol: PRKCH
1 Cross references
237 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSRFEG00010001239
Gene Symbol: PRKCI
1 Cross references
195 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSRFEG00010016507
Gene Symbol: PRKCQ
1 Cross references
203 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSRFEG00010014771
Gene Symbol: PRKCZ
1 Cross references
198 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSRFEG00010001259
Gene Symbol: PRKD1
1 Cross references
204 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSRFEG00010011443
Gene Symbol: PRKD3
1 Cross references
270 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Alpha

Ensembl ID : ENSRFEG00010009863
Gene Symbol: PRKACA
1 Cross references
283 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Beta

Ensembl ID : ENSRFEG00010007567
Gene Symbol: PRKACB
1 Cross references
297 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSRFEG00010012932
Gene Symbol: PRKDC
1 Cross references
184 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).